National Health Investors (NYSE:NHI) Stock Picked Up by Analysts at Huntington

Equities researchers at Huntington initiated coverage on shares of National Health Investors (NYSE:NHI) in a research report issued to clients and investors on Monday, Zacks reports. The brokerage set a “strong-buy” rating on the real estate investment trust’s stock.

A number of other equities research analysts have also weighed in on the stock. National Bank Financial set a $79.00 price objective on shares of National Health Investors in a report on Wednesday, September 9th. Zacks Research upgraded shares of National Health Investors from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. Truist Financial dropped their target price on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, September 2nd. Weiss Ratings lowered shares of National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, September 25th. Finally, Wells Fargo & Company decreased their price target on shares of National Health Investors from $78.00 to $68.00 and set an “equal weight” rating for the company in a research note on Monday, October 19th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, National Health Investors presently has an average rating of “Moderate Buy” and a consensus target price of $81.00.

National Health Investors Stock Down 4.6%

NYSE:NHI opened at $67.96 on Monday. National Health Investors has a twelve month low of $63.51 and a twelve month high of $91.38. The company has a market cap of $3.34 billion, a price-to-earnings ratio of 4.77, a price-to-earnings-growth ratio of 4.54 and a beta of 0.51. The stock has a fifty day simple moving average of $67.74 and a 200-day simple moving average of $76.08. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI) last issued its earnings results on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $10.29. The firm had revenue of $113.48 million during the quarter, compared to analyst estimates of $68.53 million. National Health Investors had a net margin of 152.82% and a return on equity of 45.12%. Analysts anticipate that National Health Investors will post 4.76 EPS for the current year.

Institutional Trading of National Health Investors

Hedge funds have recently bought and sold shares of the stock. BlackRock Inc. purchased a new position in shares of National Health Investors in the 2nd quarter valued at $665,997,000. Principal Financial Group Inc. lifted its stake in shares of National Health Investors by 2.0% during the 1st quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock worth $137,537,000 after purchasing an additional 32,902 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in National Health Investors during the second quarter valued at about $122,509,000. Bank of America Corp DE bought a new stake in National Health Investors during the second quarter valued at about $77,738,000. Finally, Dimensional Fund Advisors LP grew its stake in National Health Investors by 2.7% in the first quarter. Dimensional Fund Advisors LP now owns 686,249 shares of the real estate investment trust’s stock valued at $55,493,000 after purchasing an additional 18,164 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors News Summary

Here are the key news stories impacting National Health Investors this week:

• Positive Sentiment: NHI outlined a target for high-single-digit to low-double-digit organic same-store senior housing operating portfolio (SHOP) NOI growth, signaling potential operating growth. Article: NHI outlines 2026 guidance and SHOP growth target
• Positive Sentiment: NHI declared a quarterly dividend of $0.94 per share, a potentially supportive feature for income-focused investors. Article: National Health Investors declares dividend
• Negative Sentiment: Third-quarter FFO was $1.12 per share, down from $1.32 a year earlier and below Zacks’ $1.17 consensus estimate, though it matched FactSet’s estimate. That decline may concern investors focused on recurring REIT performance. Article: National Health Investors misses Q3 FFO and revenue estimates
• Negative Sentiment: Full-year 2026 normalized FFO guidance of $4.68–$4.70 per share is below the cited analyst consensus of $4.76, creating a modest earnings-expectations headwind. Article: NHI outlines 2026 guidance
• Negative Sentiment: Operating partners are dealing with community transitions and a muted summer selling season, which could weigh on near-term occupancy, operations, or transaction activity. Article: NHI operating partners face transitions and muted selling season

National Health Investors Company Profile

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.